Duality Biotherapeutics, Inc. (HKG:9606)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
324.60
+11.60 (3.71%)
Mar 10, 2026, 3:55 PM HKT

Duality Biotherapeutics Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023
Period Ending
Mar '26 Dec '24 Dec '23
Debt / Equity Ratio
0.020.000.00
Debt / EBITDA Ratio
--0.01
Debt / FCF Ratio
0.100.020.01
Net Debt / Equity Ratio
-1.250.691.01
Net Debt / EBITDA Ratio
17.677.58-1.53
Net Debt / FCF Ratio
-5.25-4.94-1.40
Asset Turnover
-1.08-
Quick Ratio
4.660.480.50
Current Ratio
4.730.490.52
Return on Assets (ROA)
--6.51%-
Return on Capital Employed (ROCE)
-6.40%10.50%-69.40%
Source: S&P Capital IQ. Standard template. Financial Sources.